These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 24161471)

  • 1. The innate and adaptive immunological aspects in neurodegenerative diseases.
    Rodrigues MC; Sanberg PR; Cruz LE; Garbuzova-Davis S
    J Neuroimmunol; 2014 Apr; 269(1-2):1-8. PubMed ID: 24161471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodegenerative diseases: The immunological perspective.
    Molteni M; Rossetti C
    J Neuroimmunol; 2017 Dec; 313():109-115. PubMed ID: 29153601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of innate immune receptors in neurodegenerative diseases: a similar pattern.
    Letiembre M; Liu Y; Walter S; Hao W; Pfander T; Wrede A; Schulz-Schaeffer W; Fassbender K
    Neurobiol Aging; 2009 May; 30(5):759-68. PubMed ID: 17905482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate Immunity: A Common Denominator between Neurodegenerative and Neuropsychiatric Diseases.
    Novellino F; Saccà V; Donato A; Zaffino P; Spadea MF; Vismara M; Arcidiacono B; Malara N; Presta I; Donato G
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear receptors, inflammation, and neurodegenerative diseases.
    Saijo K; Crotti A; Glass CK
    Adv Immunol; 2010; 106():21-59. PubMed ID: 20728023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To be or not to be (inflamed)--is that the question in anti-inflammatory drug therapy of neurodegenerative disorders?
    Marchetti B; Abbracchio MP
    Trends Pharmacol Sci; 2005 Oct; 26(10):517-25. PubMed ID: 16126283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunology meets neuroscience--opportunities for immune intervention in neurodegenerative diseases.
    Lynch MA; Mills KH
    Brain Behav Immun; 2012 Jan; 26(1):1-10. PubMed ID: 21664452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing mitophagy as a therapeutic approach for neurodegenerative diseases.
    Aman Y; Ryan B; Torsetnes SB; Knapskog AB; Watne LO; McEwan WA; Fang EF
    Int Rev Neurobiol; 2020; 155():169-202. PubMed ID: 32854854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leprosy susceptibility: genetic variations regulate innate and adaptive immunity, and disease outcome.
    Cardoso CC; Pereira AC; de Sales Marques C; Moraes MO
    Future Microbiol; 2011 May; 6(5):533-49. PubMed ID: 21585261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral Immunosenescence and Central Neuroinflammation: A Dangerous Liaison - A Dietary Approach.
    Magrone T; Magrone M; Russo MA; Jirillo E
    Endocr Metab Immune Disord Drug Targets; 2020; 20(9):1391-1411. PubMed ID: 32250234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy and self-defense.
    Martínez-Borra J; López-Larrea C
    Adv Exp Med Biol; 2012; 738():169-84. PubMed ID: 22399380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders.
    Gendelman HE; Mosley RL
    J Neuroimmune Pharmacol; 2015 Dec; 10(4):645-50. PubMed ID: 26520433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodegeneration in tauopathies and synucleinopathies.
    Foguem C; Kamsu-Foguem B
    Rev Neurol (Paris); 2016 Nov; 172(11):709-714. PubMed ID: 27344208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate and adaptive immune responses in neurodegeneration and repair.
    Amor S; Woodroofe MN
    Immunology; 2014 Mar; 141(3):287-91. PubMed ID: 23758741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseases.
    Sheta EA; Appel SH; Goldknopf IL
    Expert Rev Proteomics; 2006 Feb; 3(1):45-62. PubMed ID: 16445350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging roles of innate and adaptive immunity in Alzheimer's disease.
    Chen X; Holtzman DM
    Immunity; 2022 Dec; 55(12):2236-2254. PubMed ID: 36351425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate Immunity and Neurodegeneration.
    Labzin LI; Heneka MT; Latz E
    Annu Rev Med; 2018 Jan; 69():437-449. PubMed ID: 29106805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunotherapy targeting misfolded proteins in neurodegenerative disease].
    Kanemaru K
    Brain Nerve; 2013 Apr; 65(4):469-74. PubMed ID: 23568995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapeutic strategies for neurodegenerative diseases.
    Baekelandt V; De Strooper B; Nuttin B; Debyser Z
    Curr Opin Mol Ther; 2000 Oct; 2(5):540-54. PubMed ID: 11249757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.